
GenBioPro
Pharmaceutical companyWikipedia
5
MENTIONS
5
EPISODES
4
PODCASTS
Search complete. 5 mentions across 5 episodes found for "GenBioPro".
Oct 1, 2026
Wired In: The GOP’s Midterm Nightmare?
G
29:55Gabrielle McIntyreGUEST
Yeah, so facilitated, obviously, by the FDA's decision, it's a very coordinated effort.
G
30:02Gabrielle McIntyreGUEST
Not only do you have facilitators like Aid Access, for example, advertising where you can get these drugs in pro-life states where they're unlawful, you also have the manufacturers of the drugs, Danko and GenBioPro, their own websites also linked to website portals that will tell women how to get these drugs in states where they're unlawful.
G
30:21Gabrielle McIntyreGUEST
So you see this trickle down where it's an entire scheme.
G
30:24Gabrielle McIntyreGUEST
Of course, the FDA itself doesn't send abortion drugs across state lines.
Louisiana vs. The Food and Drug Administration
O
0:49Olivia SzczepanskiHOST
Now, the plaintiffs are represented by attorneys from the Alliance Defending Freedom, or the ADF, and the defendants are represented by attorneys from the U.S. Department of Justice.
O
1:01Olivia SzczepanskiHOST
And the intervener or defendant, Danko Laboratories, is represented by private counsel, the firm O'Melveny & Myers LLP, and the intervener defendant, GenBioPro, is represented by lawyers from the Democracy Forward Foundation.
J
1:20Julianne Morris-ScottHOST
Some quick background on Markazich.
J
1:22Julianne Morris-ScottHOST
She is a Louisiana resident who was part of the lawsuit because of her claims that her boyfriend tried to coerce her into ending a pregnancy by mailing abortion pills from an out-of-state provider.
USCA, Fifth Circuit Louisiana v. FDA, Case No. 26-30203
J
73:35Jessica EllsworthUNKNOWN
Thank you, Your Honors.
J
73:43John ElwoodUNKNOWN
May it please the court, John Elwood for intervener, GenBioPro.
J
73:47John ElwoodUNKNOWN
I just want to begin first by following up on one of Judge Richmond's questions about what exactly is at issue here.
J
73:54John ElwoodUNKNOWN
The REMS modification here was a very modest one.
FDA Wouldn’t Defend Its Own Mifepristone Rule in Court
I
5:17Imani GandyHOST
Actually, that rule traced back to a 2021 review that a federal court in Hawaii had already ordered.
I
5:24Imani GandyHOST
GenBioPro's lawyer then stood up and took apart Louisiana's scariest number.
I
5:30Imani GandyHOST
Louisiana claims that ER visits jumped from 4% to 11% after the in-person requirement was lifted, but the real number is 6 to 8%, and even that doesn't mean that anything went wrong.
I
5:44Imani GandyHOST
Half the people that went to the ER got checked out and sent home, no problem.
Louisiana Says It's ‘Blanketed’ in Contraband Mifepristone
I
4:40Imani GandyHOST
In-person dispensing back on the books everywhere while the appeal plays out.
I
4:45Imani GandyHOST
Now, here come the pharma companies, GenBioPro and Danco, who manufacture Miffy, went to the Supreme Court and asked the court to freeze the Fifth Circuit order suspending the FDA rule.
I
4:59Imani GandyHOST
And the Supreme Court said yes, with Thomas and Alito dissenting because surprise, surprise.
I
5:04Imani GandyHOST
Thomas went so far in his dissent as to say the manufacturers of mifepristone weren't entitled to protection from lost profits from their, quote, criminal enterprise.